Clinical Trial: A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07025577) titled 'A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions' on May 30.

Brief Summary: This study will evaluate the safety and tolerability of SC administration of IgG in healthy participants.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: Immunoglobulin G

Participants will receive SC administrations of IgG

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Genentech, Inc.

Disclaimer: Curated by HT Syndication....